![Dani Stoltzfus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dani Stoltzfus formerly worked at NeuBase Therapeutics, Inc., as Vice President-Research from 2020 to 2023.
Dr. Stoltzfus received her undergraduate degree, graduate degree, and doctorate degree from Flinders University.
| Bedrijven | Functie | Einde |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-08-2023 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Flinders University
 Flinders University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
